Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q2 2019 Earnings

1MayConfirmed

Q3 2018

Q4 2018

Q1 2019

Q2 2019

-9.06

-8.19

-7.32

-6.45

Details

Expected EPS

-8.191336999999999

Actual EPS

-6.7803889999999996

Surprise EPS

1.41

Surprise Percent

+17.22%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -6.7803889999999996 per share for Q2 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.